SRRM1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.347800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.605430E-01
Normal-vs-Stage2
1.030960E-01
Normal-vs-Stage3
8.259800E-02
Normal-vs-Stage4
6.309000E-01
Stage1-vs-Stage2
7.489200E-01
Stage1-vs-Stage3
8.173800E-02
Stage1-vs-Stage4
1.908260E-02
Stage2-vs-Stage3
7.033800E-02
Stage2-vs-Stage4
3.616000E-03
Stage3-vs-Stage4
1.228340E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.508100E-02
Normal-vs-AfricanAmerican
4.414400E-01
Normal-vs-Asian
1.153020E-01
Caucasian-vs-AfricanAmerican
6.352800E-01
Caucasian-vs-Asian
4.194600E-01
AfricanAmerican-vs-Asian
4.336400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.394000E-02
Normal-vs-Female
1.564410E-01
Male-vs-Female
5.508400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.148600E-01
Normal-vs-Age(41-60Yrs)
2.935400E-01
Normal-vs-Age(61-80Yrs)
5.751800E-02
Normal-vs-Age(81-100Yrs)
6.646000E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.118000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.808400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.954600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.004400E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.650500E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.821600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.207800E-02
Normal-vs-Daily Drinker
1.070580E-01
Normal-vs-Weekly Drinker
4.808100E-02
Normal-vs-Occasional Drinker
4.322000E-01
Normal-vs-Social Drinker
1.312040E-01
Non Drinker-vs-Daily Drinker
7.812800E-01
Non Drinker-vs-Weekly Drinker
7.678600E-01
Non Drinker-vs-Occasional Drinker
5.124500E-02
Non Drinker-vs-Social Drinker
3.454800E-01
Daily Drinker-vs-Weekly Drinker
5.986200E-01
Daily Drinker-vs-Occasional Drinker
1.114590E-01
Daily Drinker-vs-Social Drinker
5.161800E-01
Weekly Drinker-vs-Occasional Drinker
4.772400E-02
Weekly Drinker-vs-Social Drinker
2.121400E-01
Occasional Drinker-vs-Social Drinker
3.179200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.109440E-01
Normal-vs-Grade 2
6.501100E-03
Normal-vs-Grade 3
1.345790E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.479800E-02
Grade 1-vs-Grade 3
5.818500E-02
Grade 1-vs-Grade 4
1.109440E-01
Grade 2-vs-Grade 3
9.735800E-01
Grade 2-vs-Grade 4
6.501100E-03
Grade 3-vs-Grade 4
1.345790E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.885600E-02
Normal-vs-NonDiabetic
5.986000E-02
Diabetic-vs-NonDiabetic
7.416600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.636050E-01
Normal-vs-NoPancreatitis
6.534400E-02
Pancreatitis-vs-NoPancreatitis
6.101200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.201430E-01
Normal-vs-N1
9.875600E-02
N0-vs-N1
7.065400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.446800E-01
Normal-vs-TP53-NonMutant
1.194400E-01
TP53-Mutant-vs-TP53-NonMutant
9.322000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
